Gene · 5378
Papers1,886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,886
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival. | Oncotarget | 2022 | 35720978 | PubTator, text mining | PubMed |
| Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey. | Front Oncol | 2022 | 35692798 | PubTator, text mining | PubMed |
| Genomic characterization of lymphomas in patients with inborn errors of immunity. | Blood Adv | 2022 | 35687490 | PubTator, text mining | PubMed |
| The current state of molecular profiling in gastrointestinal malignancies. | Biol Direct | 2022 | 35668531 | PubTator, text mining | PubMed |
| The Interplay of Four Main Pathways Recomposes Immune Landscape in Primary and Metastatic Gastroenteropancreatic Neuroendocrine Tumors. | Front Oncol | 2022 | 35664743 | PubTator, text mining | PubMed |
| Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion. | J Cancer Res Clin Oncol | 2022 | 35648195 | PubTator, text mining | PubMed |
| Flavivirus Capsid Proteins Inhibit the Interferon Response. | Viruses | 2022 | 35632712 | PubTator, text mining | PubMed |
| The Role of DNA Repair in Genomic Instability of Multiple Myeloma. | Int J Mol Sci | 2022 | 35628498 | PubTator, text mining | PubMed |
| A Glimpse of Molecular Biomarkers in Huntington's Disease. | Int J Mol Sci | 2022 | 35628221 | PubTator, text mining | PubMed |
| Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers-A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference. | Curr Oncol | 2022 | 35621647 | PubTator, text mining | PubMed |
| PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy. | Curr Oncol | 2022 | 35621626 | PubTator, text mining | PubMed |
| Microsatellite instability and chemosensitivity in solid tumours. | Ther Adv Med Oncol | 2022 | 35620236 | PubTator, text mining | PubMed |
| Cancer Risk C (CR-C), a functional genomics test is a sensitive and rapid test for germline mismatch repair deficiency. | Genet Med | 2022 | 35616648 | PubTator, text mining | PubMed |
| Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variants. | Sci Rep | 2022 | 35595798 | PubTator, text mining | PubMed |
| DNA damage and repair in the hematopoietic system. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35593466 | PubTator, text mining | PubMed |
| A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response. | Cell Rep Med | 2022 | 35584624 | PubTator, text mining | PubMed |
| Statistical methods for Mendelian models with multiple genes and cancers. | Genet Epidemiol | 2022 | 35583099 | PubTator, text mining | PubMed |
| Endometrioid endometrial carcinoma of no-specific-molecular-profile with multiple bone metastases and muscle involvement: Case report and review of the literature. | Radiol Case Rep | 2022 | 35570879 | PubTator, text mining | PubMed |
| High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome. | Cancers (Basel) | 2022 | 35565214 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5378/papers?page=17